tranexamic acid has been researched along with Intertrochanteric Fractures in 77 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Excerpt | Relevance | Reference |
---|---|---|
"To compare the efficacy of different dosages of intravenous (IV) tranexamic acid (TXA) in the treatment of traumatic hip fractures against that of the control group of no TXA." | 9.41 | The Efficacy of Tranexamic Acid for the Treatment of Traumatic Hip Fractures: A Network Meta-Analysis. ( Bloom, DA; Chapman, CB; Konda, SR; Lin, CC; Manzi, JE; Mojica, ES; Telgheder, ZL, 2023) |
"Meta-analyses on the use of tranexamic acid (TXA) in intertrochanteric fractures have shown inconsistent results due to variations in inclusion criteria and clinical heterogeneity." | 9.41 | Intravenous application of tranexamic acid in intramedullary nailing for the treatment of geriatric intertrochanteric fractures: a systematic review and meta-analysis. ( Fan, X; Wu, J; Yuan, X; Zhang, J; Zheng, Y, 2023) |
"To investigate the efficacy and safety of intravenous combined with topical administration of tranexamic acid (TXA) in reducing blood loss after intramedullary fixation of intertrochanteric femoral fractures by a prospective controlled trial." | 9.41 | [Efficacy and safety of intravenous combined with topical administration of tranexamic acid in reducing blood loss after intramedullary fixation of intertrochanteric femoral fractures]. ( Gong, D; Gou, Y; Li, H; Li, W; Liu, D; Tang, X; Wang, N; Wu, Y; Zhang, Y, 2021) |
"Local administration of tranexamic acid is associated with a reduced total blood loss, postoperative hemoglobin decline, and transfusion requirements in patients with intertrochanteric fractures." | 8.95 | Tranexamic acid reduces blood loss in intertrochanteric fractures: A meta-analysis from randomized controlled trials. ( Wang, W; Yu, J, 2017) |
"Tranexamic acid (TXA) has been shown to reduce intraoperative bleeding and the need for post-operative allogenic blood transfusion requirement in surgery." | 7.11 | A single dose of tranexamic acid infusion is safe and effective to reduce total blood loss during proximal femoral nailing for intertrochanteric fractures: A prospective randomized study. ( Ekinci, M; Ersin, M; Günen, E; Kocazeybek, E; Ok, M; Sırma, SÖ; Yılmaz, M, 2022) |
"Tranexamic acid (TXA) has been shown to reduce perioperative blood loss in elective orthopedic surgery." | 7.01 | Topical tranexamic acid in hip fractures: a randomized, placebo-controlled double-blinded study. ( Cheong, Y; Costain, D; Elder, G; Fera, L; Fraser, B; Kelly, A; Slagel, B, 2021) |
"A total of 100 patients with intertrochanteric fractures undergoing surgery were enrolled and randomly allocated to the TXA group in which patients (75." | 6.90 | Efficacy and Safety of Tranexamic Acid in Intertrochanteric Fractures: A Single-Blind Randomized Controlled Trial. ( Huang, Y; Jiang, LF; Wu, LD; Xu, NW; Zhang, JJ; Zhang, Y; Zhou, D; Zhou, XD, 2019) |
" There were no complications or adverse effects related to the evaluated interventions." | 6.90 | Prevention of postoperative bleeding in hip fractures treated with prosthetic replacement: efficacy and safety of fibrin sealant and tranexamic acid. A randomised controlled clinical trial (TRANEXFER study). ( Aguilera, X; Bosch, A; Camacho-Carrasco, P; Castillón, P; González, JC; Hernández, JA; Jordan, M; Martínez-Zapata, MJ; Mora, JM; Prat-Fabregat, S; Rodriguez-Arias, A; Ruiz, L; Salomó, M, 2019) |
"To compare the efficacy of different dosages of intravenous (IV) tranexamic acid (TXA) in the treatment of traumatic hip fractures against that of the control group of no TXA." | 5.41 | The Efficacy of Tranexamic Acid for the Treatment of Traumatic Hip Fractures: A Network Meta-Analysis. ( Bloom, DA; Chapman, CB; Konda, SR; Lin, CC; Manzi, JE; Mojica, ES; Telgheder, ZL, 2023) |
"Meta-analyses on the use of tranexamic acid (TXA) in intertrochanteric fractures have shown inconsistent results due to variations in inclusion criteria and clinical heterogeneity." | 5.41 | Intravenous application of tranexamic acid in intramedullary nailing for the treatment of geriatric intertrochanteric fractures: a systematic review and meta-analysis. ( Fan, X; Wu, J; Yuan, X; Zhang, J; Zheng, Y, 2023) |
"To investigate the efficacy and safety of intravenous combined with topical administration of tranexamic acid (TXA) in reducing blood loss after intramedullary fixation of intertrochanteric femoral fractures by a prospective controlled trial." | 5.41 | [Efficacy and safety of intravenous combined with topical administration of tranexamic acid in reducing blood loss after intramedullary fixation of intertrochanteric femoral fractures]. ( Gong, D; Gou, Y; Li, H; Li, W; Liu, D; Tang, X; Wang, N; Wu, Y; Zhang, Y, 2021) |
"Local administration of tranexamic acid is associated with a reduced total blood loss, postoperative hemoglobin decline, and transfusion requirements in patients with intertrochanteric fractures." | 4.95 | Tranexamic acid reduces blood loss in intertrochanteric fractures: A meta-analysis from randomized controlled trials. ( Wang, W; Yu, J, 2017) |
"To determine whether locally injected tranexamic acid (TXA) used in the surgical treatment of fragility hip fractures can lower transfusion rates without increasing the risk of complications." | 4.12 | Efficacy and Safety of Locally Injected Tranexamic Acid in Hip Fracture Patients: A Retrospective Review. ( Davis, S; Kumar, M; Shearier, E; Solomito, MJ; Witmer, D, 2022) |
"The aim of this pre and post interventional study looks at the effects of intravenous administration of tranexamic acid on induction for elderly patients undergoing hemiarthroplasty or intramedullary nail fixation for hip fractures." | 4.02 | The efficacy of intravenous tranexamic acid administration at induction in definitive hip fracture surgery: Is there a role? ( Chakravarty, D; Guhan, B; Kanthasamy, S; Parker, MJ, 2021) |
"The specific method and dose of tranexamic acid (TXA) topically applied for intertrochanteric fractures have not been well established." | 4.02 | Effect and safety of topical application of tranexamic acid to reduce perioperative blood loss in elderly patients with intertrochanteric fracture undergoing PFNA. ( He, J; Huang, T; Wei, H; Xia, M; Xian, S; Xiao, Q; Xu, W, 2021) |
"We investigated the clinical application of auricular point sticking (APS) combined with tranexamic acid in perioperative hemostasis in elderly patients with intertrochanteric fractures of the femur." | 3.91 | Clinical application of auricular point sticking in perioperative hemostasis for elderly patients with intertrochanteric fractures of the femur. ( Er, Z; Yin, C; Zhang, J, 2019) |
"Geriatric hip fracture patients are particularly susceptible to blood loss and venous thromboembolism (VTE) during hemiarthroplasty, yet relatively few studies have examined the safety and efficacy of tranexamic acid (TXA) in these patients." | 3.91 | Efficacy and safety of tranexamic acid in geriatric hip fracture with hemiarthroplasty: a retrospective cohort study. ( Chen, G; Hu, Q; Huang, Q; Pei, F; Xie, J; Zhou, Z, 2019) |
"Tranexamic acid (TXA) has been shown to reduce intraoperative bleeding and the need for post-operative allogenic blood transfusion requirement in surgery." | 3.11 | A single dose of tranexamic acid infusion is safe and effective to reduce total blood loss during proximal femoral nailing for intertrochanteric fractures: A prospective randomized study. ( Ekinci, M; Ersin, M; Günen, E; Kocazeybek, E; Ok, M; Sırma, SÖ; Yılmaz, M, 2022) |
"Elderly patients with intertrochanteric fractures exhibit post-traumatic hidden blood loss (HBL)." | 3.01 | Early intravenous tranexamic acid intervention reduces post-traumatic hidden blood loss in elderly patients with intertrochanteric fracture: a randomized controlled trial. ( Chen, X; He, T; Li, M; Liu, L; Liu, X; Long, X; Ma, H; Wang, H; Wang, W; Xu, Z, 2021) |
"Osteoporotic hip fractures are a major health problem in developed countries." | 3.01 | Intravenous tranexamic acid and thromboembolic events in hip fracture surgery: A systematic review and meta-analysis. ( Leverett, GD; Marriott, A, 2023) |
"Anemia is one of the most common complications after hip fracture surgery." | 3.01 | Tranexamic acid in hip hemiarthroplasty surgery: a systematic review and meta-analysis. ( Augustinus, S; Gardenbroek, TJ; Goslings, JC; Mulders, MAM, 2023) |
"Tranexamic acid was given intravenously or topically during the perioperative period." | 3.01 | Interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery: an overview of systematic reviews. ( Estcourt, LJ; Griffin, XL; Lewis, SR; Pritchard, MW; Stanworth, SJ, 2023) |
"Tranexamic acid (TXA) has been shown to reduce perioperative blood loss in elective orthopedic surgery." | 3.01 | Topical tranexamic acid in hip fractures: a randomized, placebo-controlled double-blinded study. ( Cheong, Y; Costain, D; Elder, G; Fera, L; Fraser, B; Kelly, A; Slagel, B, 2021) |
"A total of 100 patients with intertrochanteric fractures undergoing surgery were enrolled and randomly allocated to the TXA group in which patients (75." | 2.90 | Efficacy and Safety of Tranexamic Acid in Intertrochanteric Fractures: A Single-Blind Randomized Controlled Trial. ( Huang, Y; Jiang, LF; Wu, LD; Xu, NW; Zhang, JJ; Zhang, Y; Zhou, D; Zhou, XD, 2019) |
" There were no complications or adverse effects related to the evaluated interventions." | 2.90 | Prevention of postoperative bleeding in hip fractures treated with prosthetic replacement: efficacy and safety of fibrin sealant and tranexamic acid. A randomised controlled clinical trial (TRANEXFER study). ( Aguilera, X; Bosch, A; Camacho-Carrasco, P; Castillón, P; González, JC; Hernández, JA; Jordan, M; Martínez-Zapata, MJ; Mora, JM; Prat-Fabregat, S; Rodriguez-Arias, A; Ruiz, L; Salomó, M, 2019) |
"Eligible patients with trochanteric fractures surgically treated by dynamic hip screw and proximal anti-rotating intramedullary nail between March 2016 and October 2017 were enrolled in the study." | 2.90 | Efficacy and safety of perioperative tranexamic acid in elderly patients undergoing trochanteric fracture surgery: a randomised controlled trial. ( Chen, F; Jiang, Z; Li, M; Zhu, X, 2019) |
"This meta-analysis provides strong evidence that TXA is a safe and effective agent to reduce perioperative blood loss in hip fracture surgery." | 2.82 | Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: A meta-analysis of randomized controlled trials. ( Antoniou, G; Masouros, P; Nikolaou, VS, 2022) |
" Then, subgroup and meta-regression analyses were conducted to disclose the influence of geographic area, fracture type, administration route, frequency and dosage of TXA, blood transfusion threshold, and follow-up duration on the overall effect." | 2.82 | Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice. ( Deng, S; Liang, J; Liu, W, 2022) |
"Tranexamic acid (TXA) use has expanded across many surgical specialties." | 2.72 | The Use of Tranexamic Acid in Hip and Pelvic Fracture Surgeries. ( Adams, JD; Marshall, WA, 2021) |
"Tranexamic acid (TXA) has been widely used to decrease blood loss and transfusion rates in joint replacement surgery." | 2.55 | Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis: A meta-analysis. ( Chen, P; Fang, Y; He, J; Liang, Y; Wang, J; Zhang, P, 2017) |
"Tranexamic acid (TXA) has long been the antifibrinolytic hemostatic drug of choice for orthopedic surgery." | 1.91 | Efficacy and safety of using aminocaproic acid and tranexamic acid during the perioperative period for treating trochanteric fractures in elderly femurs. ( Haibier, A; Qin, Q; Ran, J; Ren, Z; Yusufu, A; Zhang, Z; Zhou, Y, 2023) |
"The use of tranexamic acid is effective in reduction of blood loss and rates of blood transfusion, without an apparent increase in adverse thromboembolic events." | 1.72 | Efficacy and safety of tranexamic acid in hip fracture surgery: A comparative study of 613 patients. ( AlSumadi, M; Ashour, R; Banim, R; Kharma, L; Mahmood, A; Whittam, D, 2022) |
"Tranexamic acid (TXA) has shown to significantly reduce perioperative blood loss in elective orthopedic joint replacement surgery but is yet not implemented in acute hip fracture surgery for elderly patients who are particularly vulnerable to perioperative blood loss and postoperative anemia." | 1.72 | Clinical outcomes of tranexamic acid in acute hip hemiarthroplasties in frail geriatric patients. ( de Jong, L; Kuijper, TM; Roukema, GR; van Rijckevorsel, VAJIM, 2022) |
"Tranexamic acid was used less often in the CTHA group (p < 0." | 1.72 | Conversion total hip arthroplasty for early failure following unstable intertrochanteric hip fracture: what can patients expect? ( Egol, KA; Penev, A; Schultz, BJ; Schwarzkopf, R; Sicat, C, 2022) |
"Tranexamic acid (TXA) is a drug used to control hemorrhage by preventing the breakdown of fibrin." | 1.62 | The Efficacy and Safety of Tranexamic Acid Treatment in Orthopaedic Trauma Surgery. ( Egol, KA; Littlefield, CP; Perskin, CR; Umeh, U; Wang, C, 2021) |
" Thus, we conclude that it is safe to use TXA in this patient group." | 1.62 | Is tranexamic acid use in patients with a hip fracture safe? ( Andersen, LR; Clemmensen, SB; Gundtoft, PH; Halekoh, U; Lauritsen, J; Madsen, CF; Overgaard, S; Pedersen, L; Schønnemann, JO; Titlestad, K; Viberg, B, 2021) |
" Our study indicates that the local administration of TXA/DEP is safe and more effective than the administration of TXA alone in treating trochanteric femoral fractures." | 1.56 | Safety and efficacy of tranexamic acid with epinephrine for prevention of blood loss following surgery for trochanteric femoral fractures. ( Hu, Y; Xie, L; Xu, X; Yu, H, 2020) |
"Tranexamic acid (TXA) has proven efficacy in decreasing blood loss in general trauma patients as well as patients undergoing elective orthopaedic surgery." | 1.43 | Tranexamic acid in hip fracture patients: a protocol for a randomised, placebo controlled trial on the efficacy of tranexamic acid in reducing blood loss in hip fracture patients. ( Flores, E; Garner, MR; Gausden, EB; Levack, A; Lorich, DG; Nellestein, AM; Tedore, T; Warner, SJ, 2016) |
"Tranexamic acid (TXA) has been shown to reduce perioperative blood loss in elective lower limb arthroplasty surgery." | 1.42 | The efficacy of tranexamic acid in hip hemiarthroplasty surgery: an observational cohort study. ( Edmondson, M; Freeman, R; Lee, C; Rogers, BA, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 23 (29.87) | 24.3611 |
2020's | 54 (70.13) | 2.80 |
Authors | Studies |
---|---|
Schultz, BJ | 1 |
Sicat, C | 1 |
Penev, A | 1 |
Schwarzkopf, R | 1 |
Egol, KA | 2 |
Masouros, P | 3 |
Antoniou, G | 1 |
Nikolaou, VS | 3 |
Liu, W | 1 |
Deng, S | 1 |
Liang, J | 1 |
Yee, DK | 1 |
Wong, JSH | 1 |
Fang, E | 1 |
Wong, TM | 1 |
Fang, C | 1 |
Leung, F | 1 |
Liu, J | 2 |
Lei, Y | 2 |
Liao, J | 2 |
Liang, X | 2 |
Hu, N | 2 |
Huang, W | 2 |
van Rijckevorsel, VAJIM | 1 |
Roukema, GR | 1 |
Kuijper, TM | 1 |
de Jong, L | 1 |
Cui, Y | 1 |
Lu, Y | 1 |
Huang, Q | 2 |
Zhang, C | 1 |
Sun, L | 1 |
Ren, C | 1 |
Wang, Q | 1 |
Ma, T | 1 |
Li, Z | 1 |
Zhang, K | 2 |
Wang, Z | 2 |
Xue, H | 1 |
Leverett, GD | 1 |
Marriott, A | 1 |
Porter, SB | 2 |
Spaulding, AC | 2 |
Duncan, CM | 2 |
Wilke, BK | 2 |
Pagnano, MW | 2 |
Abdel, MP | 2 |
Cornell, C | 1 |
Fenwick, A | 1 |
Antonovska, I | 1 |
Pfann, M | 1 |
Mayr, J | 1 |
Wiedl, A | 1 |
Nuber, S | 1 |
Förch, S | 1 |
Mayr, E | 1 |
Kim, CH | 1 |
Hwang, J | 1 |
Lee, SJ | 1 |
Yoon, PW | 1 |
Yoon, KS | 1 |
Sen, RK | 1 |
Attar, MU | 1 |
Saini, G | 1 |
Tripathy, SK | 1 |
Tekin, SB | 1 |
Demir, IH | 1 |
Bozgeyik, B | 1 |
Mert, A | 1 |
Miangul, S | 1 |
Oluwaremi, T | 1 |
El Haddad, J | 1 |
Adra, M | 1 |
Pinnawala, N | 1 |
Nakanishi, H | 1 |
Matar, RH | 1 |
Than, CA | 1 |
Stewart, TM | 1 |
Ekinci, M | 1 |
Ok, M | 1 |
Ersin, M | 1 |
Günen, E | 1 |
Kocazeybek, E | 1 |
Sırma, SÖ | 1 |
Yılmaz, M | 1 |
Agius, C | 3 |
Cole, E | 3 |
Mifsud, MG | 3 |
Vasireddy, A | 3 |
Augustinus, S | 2 |
Mulders, MAM | 2 |
Gardenbroek, TJ | 2 |
Goslings, JC | 2 |
Zhang, J | 3 |
Fan, X | 2 |
Zheng, Y | 2 |
Wu, J | 2 |
Yuan, X | 2 |
Bloom, DA | 1 |
Lin, CC | 1 |
Manzi, JE | 1 |
Mojica, ES | 1 |
Telgheder, ZL | 1 |
Chapman, CB | 1 |
Konda, SR | 1 |
Lewis, SR | 1 |
Pritchard, MW | 1 |
Estcourt, LJ | 1 |
Stanworth, SJ | 1 |
Griffin, XL | 1 |
Yusufu, A | 1 |
Haibier, A | 1 |
Ren, Z | 1 |
Qin, Q | 1 |
Zhang, Z | 1 |
Zhou, Y | 1 |
Ran, J | 1 |
Lasocki, S | 2 |
Capdevila, X | 1 |
Vielle, B | 2 |
Bijok, B | 1 |
Lahlou-Casulli, M | 2 |
Collange, V | 2 |
Grillot, N | 1 |
Danguy des Deserts, M | 2 |
Duchalais, A | 2 |
Delannoy, B | 1 |
Drugeon, B | 2 |
Bouzat, P | 2 |
David, JS | 2 |
Rony, L | 1 |
Loupec, T | 2 |
Léger, M | 2 |
Rineau, E | 2 |
Kenmegne, GR | 1 |
Zou, C | 1 |
Lin, Y | 1 |
Yin, Y | 1 |
Huang, S | 1 |
Banneyake, EL | 1 |
Gunasekera, IS | 1 |
Fang, Y | 2 |
Zhou, XD | 1 |
Zhang, Y | 3 |
Jiang, LF | 1 |
Zhang, JJ | 1 |
Zhou, D | 1 |
Wu, LD | 1 |
Huang, Y | 1 |
Xu, NW | 1 |
Yin, C | 1 |
Er, Z | 1 |
Yu, X | 1 |
Wang, J | 2 |
Wang, X | 1 |
Xie, L | 2 |
Chen, C | 1 |
Zheng, W | 1 |
Xing, F | 1 |
Chen, W | 1 |
Long, C | 1 |
Huang, F | 1 |
Wang, G | 1 |
Xiang, Z | 1 |
Geddes, J | 1 |
McConaghie, G | 1 |
Luo, X | 1 |
Huang, H | 2 |
Tang, X | 2 |
Xu, X | 2 |
Yu, H | 1 |
Hu, Y | 1 |
Ma, H | 2 |
Yao, H | 1 |
Zhang, T | 1 |
Wan, C | 1 |
Zhang, S | 2 |
Xiao, C | 2 |
Yu, W | 2 |
Long, N | 2 |
He, F | 1 |
Cai, P | 1 |
Luo, K | 1 |
Jiang, Y | 2 |
Muse, IO | 1 |
Montilla, E | 1 |
Gruson, KI | 1 |
Berger, J | 1 |
Parot-Schinkel, E | 1 |
Roquilly, A | 1 |
Desebbe, O | 1 |
Garrigue, D | 1 |
Mounet, B | 1 |
Hamard, F | 1 |
Wang, H | 2 |
Long, X | 1 |
Xu, Z | 1 |
Chen, X | 2 |
Li, M | 2 |
He, T | 1 |
Wang, W | 2 |
Liu, L | 1 |
Liu, X | 1 |
Kanthasamy, S | 1 |
Guhan, B | 1 |
Chakravarty, D | 1 |
Parker, MJ | 2 |
Gümüştaş, SA | 1 |
Çelen, ZE | 1 |
Onay, T | 1 |
Abul, MS | 1 |
Çevik, HB | 1 |
Floros, T | 2 |
Chronopoulos, E | 2 |
Skertsou, M | 2 |
Babis, GC | 2 |
Viberg, B | 1 |
Gundtoft, PH | 1 |
Schønnemann, JO | 1 |
Pedersen, L | 1 |
Andersen, LR | 1 |
Titlestad, K | 1 |
Madsen, CF | 1 |
Clemmensen, SB | 1 |
Halekoh, U | 1 |
Lauritsen, J | 1 |
Overgaard, S | 1 |
Suh, YS | 1 |
Nho, JH | 1 |
Seo, J | 1 |
Jang, BW | 1 |
Park, JS | 1 |
Adams, JD | 1 |
Marshall, WA | 1 |
Wadhwa, H | 1 |
Tigchelaar, SS | 1 |
Chen, MJ | 1 |
Koltsov, JCB | 1 |
Bellino, MJ | 1 |
Bishop, JA | 1 |
Gardner, MJ | 1 |
Li, H | 1 |
Liu, D | 1 |
Wang, N | 1 |
Gong, D | 1 |
Wu, Y | 1 |
Li, W | 1 |
Gou, Y | 1 |
Xu, C | 1 |
Wu, M | 1 |
Liu, Y | 2 |
Zhou, P | 1 |
Guan, J | 1 |
Bian, FC | 1 |
Cheng, XK | 1 |
An, YS | 1 |
AlSumadi, M | 1 |
Mahmood, A | 1 |
Whittam, D | 1 |
Kharma, L | 1 |
Ashour, R | 1 |
Banim, R | 1 |
Perskin, CR | 1 |
Littlefield, CP | 1 |
Wang, C | 1 |
Umeh, U | 1 |
Lin, JA | 1 |
Cui, HD | 1 |
Hong, Y | 1 |
Lyu, SJ | 1 |
Witmer, D | 1 |
Solomito, MJ | 1 |
Kumar, M | 1 |
Shearier, E | 1 |
Davis, S | 1 |
Costain, D | 1 |
Elder, G | 1 |
Fraser, B | 1 |
Slagel, B | 1 |
Kelly, A | 1 |
Cheong, Y | 1 |
Fera, L | 1 |
Wei, H | 1 |
Xiao, Q | 1 |
He, J | 2 |
Huang, T | 1 |
Xu, W | 1 |
Xian, S | 1 |
Xia, M | 1 |
Zhang, P | 1 |
Chen, P | 1 |
Liang, Y | 1 |
Lei, J | 1 |
Zhang, B | 1 |
Cong, Y | 1 |
Zhuang, Y | 1 |
Wei, X | 1 |
Fu, Y | 1 |
Wei, W | 1 |
Wang, P | 1 |
Wen, S | 1 |
Han, S | 1 |
Liu, S | 1 |
Baskaran, D | 1 |
Rahman, S | 1 |
Salmasi, Y | 1 |
Froghi, S | 1 |
Berber, O | 1 |
George, M | 1 |
Yu, J | 1 |
Tian, S | 1 |
Shen, Z | 1 |
Peng, A | 1 |
Schiavone, A | 1 |
Bisaccia, M | 1 |
Inkov, I | 1 |
Rinonapoli, G | 1 |
Manni, M | 1 |
Rollo, G | 1 |
Meccariello, L | 1 |
Vicente, CI | 1 |
Ceccarini, P | 1 |
Ruggiero, C | 1 |
Caraffa, A | 1 |
Zhu, Q | 1 |
Yu, C | 1 |
Chen, Y | 1 |
Liu, C | 1 |
Lin, P | 1 |
Peck, J | 1 |
Kepecs, DM | 1 |
Mei, B | 1 |
Safir, OA | 1 |
Backstein, D | 1 |
Gross, AE | 1 |
Kuzyk, PR | 1 |
Jordan, M | 1 |
Aguilera, X | 1 |
González, JC | 1 |
Castillón, P | 1 |
Salomó, M | 1 |
Hernández, JA | 1 |
Ruiz, L | 1 |
Mora, JM | 1 |
Camacho-Carrasco, P | 1 |
Prat-Fabregat, S | 1 |
Bosch, A | 1 |
Rodriguez-Arias, A | 1 |
Martínez-Zapata, MJ | 1 |
Jiang, W | 1 |
Shang, L | 1 |
Kashyap, S | 1 |
Mahajan, S | 1 |
Lal, M | 1 |
Chen, F | 1 |
Jiang, Z | 1 |
Zhu, X | 1 |
Xie, J | 1 |
Hu, Q | 1 |
Chen, G | 1 |
Zhou, Z | 1 |
Pei, F | 1 |
Lee, C | 1 |
Freeman, R | 1 |
Edmondson, M | 1 |
Rogers, BA | 1 |
Drakos, A | 1 |
Raoulis, V | 1 |
Karatzios, K | 1 |
Doxariotis, N | 1 |
Kontogeorgakos, V | 1 |
Malizos, K | 1 |
Varitimidis, SE | 1 |
Tengberg, PT | 1 |
Foss, NB | 1 |
Palm, H | 1 |
Kallemose, T | 1 |
Troelsen, A | 1 |
Gausden, EB | 1 |
Garner, MR | 1 |
Warner, SJ | 1 |
Levack, A | 1 |
Nellestein, AM | 1 |
Tedore, T | 1 |
Flores, E | 1 |
Lorich, DG | 1 |
Coomber, R | 1 |
Porteous, M | 1 |
Hubble, MJW | 1 |
Baruah, RK | 1 |
Borah, PJ | 1 |
Haque, R | 1 |
Zufferey, PJ | 1 |
Miquet, M | 1 |
Quenet, S | 1 |
Martin, P | 1 |
Adam, P | 1 |
Albaladejo, P | 1 |
Mismetti, P | 1 |
Molliex, S | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Comparative Use of Tranexamic Acid Intravenous and Topical Application in the Treatment of Intertrochanteric Fractures With Proximate Femoral Nail[NCT04696224] | 90 participants (Anticipated) | Interventional | 2020-12-18 | Recruiting | |||
Efficacy of Tranexamic Acid (TXA) in Humerus ORIF[NCT05802238] | Phase 2 | 130 participants (Anticipated) | Interventional | 2023-04-12 | Recruiting | ||
HiFIT Study: Interest of Intravenous Iron and Tranexamic Acid to Reduce Transfusion in Hip Fracture Patients[NCT02972294] | Phase 3 | 419 participants (Actual) | Interventional | 2017-03-31 | Terminated (stopped due to 1year inclusion hold due to PV new fact (Monofer hold for risk revaluation) DSMB Interim analysis : 1treatment with important transfusion risk reduction/inclusions issues (COVID)/sites change of practice if study continue=>stop inclusions) | ||
Topical Tranexamic Acid (TXA) in Hip Fractures, A Double-Blind, Randomized Controlled Trial[NCT02993341] | Phase 3 | 65 participants (Actual) | Interventional | 2016-11-30 | Completed | ||
The Use of Tranexamic Acid in Chinese Elderly Patients Undergoing Femoral Nailing for Intertrochanteric Fracture: A Randomized Controlled Trial[NCT04290884] | Phase 4 | 120 participants (Anticipated) | Interventional | 2018-05-23 | Active, not recruiting | ||
The Effects of the Timing of Tranexamic Acid Administration on Blood Loss in Hip Fractures.[NCT04488367] | Early Phase 1 | 120 participants (Anticipated) | Interventional | 2020-07-06 | Recruiting | ||
Efficacy of Tranexamic Acid in Femoral Shaft Fractures Osteosynthesis; A Double Blind Randomized Controlled Trial[NCT04803591] | Phase 4 | 0 participants (Actual) | Interventional | 2021-08-01 | Withdrawn (stopped due to Not approved by Ethics Commettee) | ||
Does Tranexamic Acid Significantly Reduce Total Blood Loss During Proximal Femoral Nailing for the Intertrochanteric Femoral Fracture in the Elderly?[NCT05359172] | 100 participants (Actual) | Observational | 2021-04-01 | Completed | |||
The Effect of Tranexamic Acid on Transfusion Rates in Intertrochanteric Hip Fractures: A Prospective, Double-Blind, Randomized Controlled Trial[NCT01940536] | Phase 4 | 0 participants (Actual) | Interventional | 2015-12-31 | Withdrawn (stopped due to Possible change in study protocol) | ||
Efficacy of Tranexamic Acid on Perioperative Blood Loss During Hip Fracture Surgery.[NCT00327106] | Phase 3 | 110 participants (Actual) | Interventional | 2005-04-30 | Completed | ||
Evaluation of the Safety and Efficacy of the Second Dose of Tranexamic Acid Administration of Trauma Patients: A Randomized, Double-blind Controlled Clinical Trial[NCT03846973] | Phase 3 | 220 participants (Actual) | Interventional | 2018-12-02 | Completed | ||
The Use of Tranexamic Acid to Reduce Blood Loss in Acetabular Surgery[NCT02684851] | Phase 3 | 87 participants (Actual) | Interventional | 2012-10-31 | Completed | ||
The Impact of Topical Tranexamic Acid on Pre- and Post-operative Hemoglobin / Hematocrit in Isolated Operative Posterior Wall Acetabular Fractures: a Prospective, Randomized, Double-blinded, Multicenter Study[NCT05357079] | Early Phase 1 | 98 participants (Anticipated) | Interventional | 2017-08-25 | Recruiting | ||
The Effect of Preoperative Tranexamic Acid on Blood Loss and Transfusion Rates in Intertrochanteric and Subtrochanteric Femur Fractures.[NCT02580227] | Phase 4 | 100 participants (Anticipated) | Interventional | 2015-06-30 | Recruiting | ||
Use of Combined Tranexamic Acid and Intravenous Iron for Hip Fracture Surgery in Elderly[NCT02428868] | 150 participants (Anticipated) | Interventional | 2015-04-30 | Not yet recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Number of participant received allogenic blood transfusions. (NCT02684851)
Timeframe: post-operative
Intervention | Participants (Count of Participants) |
---|---|
Tranexamic | 21 |
Placebo | 13 |
To measure average estimate perioperative blood loss (NCT02684851)
Timeframe: perioperative
Intervention | mL (Mean) |
---|---|
Tranexamic | 727.6 |
Placebo | 560.1 |
Do patients undergoing acetabular ORIF who receive tranexamic acid have a higher risk for thromboembolic events than patients who receive placebo? (NCT02684851)
Timeframe: 30 days
Intervention | Participants (Count of Participants) |
---|---|
Tranexamic | 1 |
Placebo | 0 |
Average units packed red blood cells transfused among participants (NCT02684851)
Timeframe: perioperative
Intervention | Units of packed red blood cells (Mean) |
---|---|
Tranexamic | 2.65 |
Placebo | 2.36 |
23 reviews available for tranexamic acid and Intertrochanteric Fractures
Article | Year |
---|---|
Efficacy and safety of tranexamic acid in hip fracture surgery. How does dosage affect outcomes: A meta-analysis of randomized controlled trials.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Hip Fractures; Humans; Randomized Controlled Tr | 2022 |
Tranexamic acid usage in hip fracture surgery: a meta-analysis and meta-regression analysis of current practice.
Topics: Administration, Topical; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgic | 2022 |
Intravenous tranexamic acid and thromboembolic events in hip fracture surgery: A systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Hemoglobins; Hip Frac | 2023 |
Tranexamic Acid Was Not Associated with Increased Complications in High-Risk Patients with Intertrochanteric Fracture.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Su | 2022 |
The effect of tranexamic acid in open reduction and internal fixation of pelvic and acetabular fracture: A systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Fracture Fixation, Internal; Hip Fractures; Humans; P | 2022 |
Update on the efficacy and safety of intravenous tranexamic acid in hip fracture surgery: a systematic review and meta-analysis.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Hip Fractures; Humans; P | 2023 |
The Use of Tranexamic Acid in Hip Fracture Surgery-A Systematic Review and Meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Hip Fractures; Humans; Tranexamic | 2022 |
The Use of Tranexamic Acid in Hip Fracture Surgery-A Systematic Review and Meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Hip Fractures; Humans; Tranexamic | 2022 |
The Use of Tranexamic Acid in Hip Fracture Surgery-A Systematic Review and Meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Hip Fractures; Humans; Tranexamic | 2022 |
The Use of Tranexamic Acid in Hip Fracture Surgery-A Systematic Review and Meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Hip Fractures; Humans; Tranexamic | 2022 |
The Use of Tranexamic Acid in Hip Fracture Surgery-A Systematic Review and Meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Hip Fractures; Humans; Tranexamic | 2022 |
The Use of Tranexamic Acid in Hip Fracture Surgery-A Systematic Review and Meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Hip Fractures; Humans; Tranexamic | 2022 |
The Use of Tranexamic Acid in Hip Fracture Surgery-A Systematic Review and Meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Hip Fractures; Humans; Tranexamic | 2022 |
The Use of Tranexamic Acid in Hip Fracture Surgery-A Systematic Review and Meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Hip Fractures; Humans; Tranexamic | 2022 |
The Use of Tranexamic Acid in Hip Fracture Surgery-A Systematic Review and Meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Hip Fractures; Humans; Tranexamic | 2022 |
Tranexamic acid in hip hemiarthroplasty surgery: a systematic review and meta-analysis.
Topics: Adult; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Hemiar | 2023 |
Tranexamic acid in hip hemiarthroplasty surgery: a systematic review and meta-analysis.
Topics: Adult; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Hemiar | 2023 |
Tranexamic acid in hip hemiarthroplasty surgery: a systematic review and meta-analysis.
Topics: Adult; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Hemiar | 2023 |
Tranexamic acid in hip hemiarthroplasty surgery: a systematic review and meta-analysis.
Topics: Adult; Anemia; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Hemiar | 2023 |
The Efficacy of Tranexamic Acid for the Treatment of Traumatic Hip Fractures: A Network Meta-Analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hip Fractures; Humans; Network Meta-Analysis; Randomi | 2023 |
Interventions for reducing red blood cell transfusion in adults undergoing hip fracture surgery: an overview of systematic reviews.
Topics: Aged; Anemia; Emergence Delirium; Erythrocyte Transfusion; Hemorrhage; Hip Fractures; Humans; Iron; | 2023 |
Intravenous application of tranexamic acid in intramedullary nailing for the treatment of geriatric intertrochanteric fractures: a systematic review and meta-analysis.
Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Fracture Fixation, | 2023 |
The efficacy and safety of tranexamic acid in the treatment of intertrochanteric fracture: an updated meta-analysis of 11 randomized controlled trials.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Female; Fracture Fixation; Hip Fractures; Human | 2020 |
Postoperative outcomes of tranexamic acid use in geriatric trauma patients treated with proximal femoral intramedullary nails: A systematic review and meta-analysis.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Fracture Fixation, Intramedullary; Hip Fracture | 2020 |
Efficacy and safety of tranexamic acid for reducing blood loss in elderly patients with intertrochanteric fracture treated with intramedullary fixation surgery: A meta-analysis of randomized controlled trials.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Fracture Fixation, Intramedullary; Hip Fracture | 2020 |
The Use of Tranexamic Acid in Hip and Pelvic Fracture Surgeries.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Hip Fractures; Humans; Tranexamic | 2021 |
Efficacy and safety of intravenous tranexamic acid administration in patients undergoing hip fracture surgery for hemostasis: A meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Hip Fractures; Humans; Orthopedic | 2017 |
Effect of tranexamic acid use on blood loss and thromboembolic risk in hip fracture surgery: systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Hemoglobins; Hip Fractures; Humans | 2018 |
Effect of tranexamic acid use on blood loss and thromboembolic risk in hip fracture surgery: systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Hemoglobins; Hip Fractures; Humans | 2018 |
Effect of tranexamic acid use on blood loss and thromboembolic risk in hip fracture surgery: systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Hemoglobins; Hip Fractures; Humans | 2018 |
Effect of tranexamic acid use on blood loss and thromboembolic risk in hip fracture surgery: systematic review and meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Hemoglobins; Hip Fractures; Humans | 2018 |
Tranexamic acid reduces blood loss in intertrochanteric fractures: A meta-analysis from randomized controlled trials.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Fracture Fixation, Internal; Hip Fractures; Humans; R | 2017 |
Efficacy and Safety of Tranexamic Acid for Blood Salvage in Intertrochanteric Fracture Surgery: A Meta-Analysis.
Topics: Hip Fractures; Humans; Operative Blood Salvage; Postoperative Complications; Thromboembolism; Tranex | 2018 |
Is intravenous tranexamic acid effective and safe during hip fracture surgery? An updated meta-analysis of randomized controlled trials.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Fract | 2019 |
Tranexamic acid can reduce blood loss in patients undergoing intertrochanteric fracture surgery: A meta-analysis.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Hematoma; Hemoglobins; Hip Fractur | 2019 |
Total hip replacement for hip fracture: Surgical techniques and concepts.
Topics: Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Comorbidity; Elective Surgical Procedures; | 2016 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
22 trials available for tranexamic acid and Intertrochanteric Fractures
Article | Year |
---|---|
Topical administration of tranexamic acid in elderly patients undergoing short femoral nailing for intertrochanteric fracture: A randomised controlled trial.
Topics: Administration, Topical; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Fracture Fixation, Int | 2022 |
Study protocol: haemostatic efficacy and safety of preemptive antifibrinolysis with multidose intravenous tranexamic acid in elderly hip fracture patients: design of a prospective randomised controlled trial.
Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Hemostatics; Hip F | 2021 |
Pre-Emptive Antifibrinolysis: Its Role and Efficacy in Hip Fracture Patients Undergoing Total Hip Arthroplasty.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Hip Fractures; | 2022 |
Safety and efficacy of perioperative tranexamic acid infusion in acetabular fracture fixation: A randomized placebo-controlled double-blind prospective study.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Fracture Fixation, Internal; Hemoglobins; Hip Fractur | 2022 |
A single dose of tranexamic acid infusion is safe and effective to reduce total blood loss during proximal femoral nailing for intertrochanteric fractures: A prospective randomized study.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Fracture Fixation, Intramedullary; Hip Fracture | 2022 |
Ferric derisomaltose and tranexamic acid, combined or alone, for reducing blood transfusion in patients with hip fracture (the HiFIT trial): a multicentre, 2 × 2 factorial, randomised, double-blind, controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Anemia; Blood Transfusion; Double-Blind Method; Female; Hemoglobins; | 2023 |
Efficacy and Safety of Tranexamic Acid in Intertrochanteric Fractures: A Single-Blind Randomized Controlled Trial.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; | 2019 |
Tranexamic acid safely reduces hidden blood loss in patients undergoing intertrochanteric fracture surgery: a randomized controlled trial.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hip Fractures; Humans; Meta-Analysis as Topic; Tranex | 2022 |
Study protocol for a multicentre, 2×2 factorial, randomised, controlled trial evaluating the interest of intravenous iron and tranexamic acid to reduce blood transfusion in hip fracture patients (the HiFIT study).
Topics: Administration, Intravenous; Anemia; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusio | 2021 |
Early intravenous tranexamic acid intervention reduces post-traumatic hidden blood loss in elderly patients with intertrochanteric fracture: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Transfusion; Female; Hemorrhage | 2021 |
Infographic: Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial.
Topics: Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Bl | 2021 |
Single dose of tranexamic acid effectively reduces blood loss and transfusion rates in elderly patients undergoing surgery for hip fracture: a randomized controlled trial.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Female; F | 2021 |
[Efficacy and safety of intravenous combined with topical administration of tranexamic acid in reducing blood loss after intramedullary fixation of intertrochanteric femoral fractures].
Topics: Administration, Intravenous; Administration, Topical; Blood Loss, Surgical; Bone Nails; Femoral Frac | 2021 |
Topical tranexamic acid in hip fractures: a randomized, placebo-controlled double-blinded study.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2021 |
Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Female; Fracture Fixation, Internal; Hip Fractures | 2017 |
Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Female; Fracture Fixation, Internal; Hip Fractures | 2017 |
Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Female; Fracture Fixation, Internal; Hip Fractures | 2017 |
Tranexamic acid reduces hidden blood loss in the treatment of intertrochanteric fractures with PFNA: a single-center randomized controlled trial.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Female; Fracture Fixation, Internal; Hip Fractures | 2017 |
The effect of tranexamic acid on hidden bleeding in older intertrochanteric fracture patients treated with PFNA.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Female; Fracture Fixation, Intramedullary; Hip | 2018 |
Prevention of postoperative bleeding in hip fractures treated with prosthetic replacement: efficacy and safety of fibrin sealant and tranexamic acid. A randomised controlled clinical trial (TRANEXFER study).
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement | 2019 |
Efficacy and safety of perioperative tranexamic acid in elderly patients undergoing trochanteric fracture surgery: a randomised controlled trial.
Topics: Administration, Intravenous; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; | 2019 |
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2016 |
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2016 |
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2016 |
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2016 |
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2016 |
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2016 |
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2016 |
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2016 |
Efficacy of Local Administration of Tranexamic Acid for Blood Salvage in Patients Undergoing Intertrochanteric Fracture Surgery.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Dou | 2016 |
Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Denmark; Double-Blind Method | 2016 |
Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Denmark; Double-Blind Method | 2016 |
Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Denmark; Double-Blind Method | 2016 |
Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Denmark; Double-Blind Method | 2016 |
Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Denmark; Double-Blind Method | 2016 |
Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Denmark; Double-Blind Method | 2016 |
Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Denmark; Double-Blind Method | 2016 |
Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Denmark; Double-Blind Method | 2016 |
Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Denmark; Double-Blind Method | 2016 |
Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Denmark; Double-Blind Method | 2016 |
Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Denmark; Double-Blind Method | 2016 |
Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Denmark; Double-Blind Method | 2016 |
Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Denmark; Double-Blind Method | 2016 |
Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Denmark; Double-Blind Method | 2016 |
Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Denmark; Double-Blind Method | 2016 |
Tranexamic acid reduces blood loss in patients with extracapsular fractures of the hip: results of a randomised controlled trial.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Denmark; Double-Blind Method | 2016 |
Use of tranexamic acid in dynamic hip screw plate fixation for trochanteric fractures.
Topics: Adult; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Bone Plates; Bone Scr | 2016 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
Tranexamic acid in hip fracture surgery: a randomized controlled trial.
Topics: Age Factors; Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Kne | 2010 |
33 other studies available for tranexamic acid and Intertrochanteric Fractures
Article | Year |
---|---|
Conversion total hip arthroplasty for early failure following unstable intertrochanteric hip fracture: what can patients expect?
Topics: Arthroplasty, Replacement, Hip; Bone Screws; Hip Fractures; Humans; Retrospective Studies; Tranexami | 2022 |
Clinical outcomes of tranexamic acid in acute hip hemiarthroplasties in frail geriatric patients.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Frail Elderly; | 2022 |
Clinical Application Effects of Different Preoperative Blood Management Schemes in Older Patients with Delayed Intertrochanteric Fracture Surgery.
Topics: Aged; Blood Loss, Surgical; Erythropoietin; Hip Fractures; Humans; Iron; Retrospective Studies; Tran | 2022 |
Administration of TXA Is Not Associated with Increased Risk of Thromboembolism, Even in Patients Considered High Risk: Commentary on an article by Steven B. Porter, MD, et al.: "Tranexamic Acid Was Not Associated with Increased Complications in High-Risk
Topics: Antifibrinolytic Agents; Hip Fractures; Humans; Thromboembolism; Tranexamic Acid | 2022 |
Does tranexamic acid reliably reduce blood loss in proximal femur fracture surgery?
Topics: Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Co | 2023 |
How does tranexamic acid affect blood transfusion and bleeding amount in pelvis-acetabulum fractures treated with open reduction and internal fixation?
Topics: Acetabulum; Blood Loss, Surgical; Blood Transfusion; Fracture Fixation, Internal; Fractures, Bone; H | 2022 |
Topical tranexamic acid in intramedullary nailing for the treatment of intertrochanteric fractures in the elderly: A protocol for systematic review and meta-analysis.
Topics: Administration, Intravenous; Administration, Topical; Aged; Antifibrinolytic Agents; Blood Loss, Sur | 2023 |
Efficacy and safety of using aminocaproic acid and tranexamic acid during the perioperative period for treating trochanteric fractures in elderly femurs.
Topics: Aged; Aminocaproic Acid; Antifibrinolytic Agents; Blood Loss, Surgical; Hip Fractures; Humans; Posto | 2023 |
A prophylactic TXA administration effectively reduces the risk of intraoperative bleeding during open management of pelvic and acetabular fractures.
Topics: Administration, Intravenous; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Hip F | 2023 |
Clinical application of auricular point sticking in perioperative hemostasis for elderly patients with intertrochanteric fractures of the femur.
Topics: Acupuncture Points; Acupuncture Therapy; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Los | 2019 |
Does perioperative use of tranexamic acid in hip fracture patients increase the risk of venous thromboembolism and reduce the need for postoperative transfusions?
Topics: Antifibrinolytic Agents; Blood Transfusion; Hip Fractures; Humans; Retrospective Studies; Tranexamic | 2020 |
Safety and efficacy of tranexamic acid with epinephrine for prevention of blood loss following surgery for trochanteric femoral fractures.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Epinephrine; Female; Fractur | 2020 |
[A comparative study of Taylor spatial frame and unilateral external fixator in treatment of tibiofibular open fractures].
Topics: Blood Loss, Surgical; External Fixators; Fracture Fixation, Internal; Fracture Healing; Fractures, O | 2020 |
Perioperative management of patients with hip fractures and COVID-19: A single institution's early experiences.
Topics: Aged; Aged, 80 and over; Anesthesia, Conduction; Antifibrinolytic Agents; COVID-19; Female; Femoral | 2020 |
The efficacy of intravenous tranexamic acid administration at induction in definitive hip fracture surgery: Is there a role?
Topics: Administration, Intravenous; Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Hip Fractures; Hum | 2021 |
The efficiency and safety of intravenous tranexamic acid administration in open reduction and internal fixation of pelvic and acetabular fractures.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hip Fractures; Humans; Pelvis; Tranexamic Acid | 2022 |
Is tranexamic acid use in patients with a hip fracture safe?
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusion; Denmark; | 2021 |
Hip Fracture Surgery without Transfusion in Patients with Hemoglobin Less Than 10 g/dL.
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Erythropoietin; Female; Hemoglobins; Hip Fractures | 2021 |
Tranexamic acid does not affect intraoperative blood loss or in-hospital outcomes after acetabular fracture surgery.
Topics: Aged; Antifibrinolytic Agents; Blood Loss, Surgical; Hip Fractures; Hospitals; Humans; Middle Aged; | 2022 |
Efficacy of repeated intravenous tranexamic acid in reducing perioperative bleeding of acetabular fractures.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hip Fractures; Humans; Retrospective Studies; Tranexa | 2021 |
Preoperative risk factors for postoperative blood transfusion after hip fracture surgery: establishment of a nomogram.
Topics: Age Factors; Aged; Aged, 80 and over; Anesthesia, General; Arthroplasty; Blood Transfusion; Calibrat | 2021 |
Efficacy and safety of tranexamic acid in hip fracture surgery: A comparative study of 613 patients.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Blood Transfusi | 2022 |
The Efficacy and Safety of Tranexamic Acid Treatment in Orthopaedic Trauma Surgery.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hip Fractures; Humans; Orthopedics; Tranexamic Acid | 2021 |
[Application of tranexamic acid in the treatment of intertrochanteric fracture of femur].
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Femur; Hip Fractures; Humans; Postoperative Hemorrhag | 2021 |
Efficacy and Safety of Locally Injected Tranexamic Acid in Hip Fracture Patients: A Retrospective Review.
Topics: Antifibrinolytic Agents; Blood Loss, Surgical; Hip Fractures; Humans; Retrospective Studies; Tranexa | 2022 |
Tranexamic Acid Was Not Associated with Increased Complications in High-Risk Patients with Hip Fracture Undergoing Arthroplasty.
Topics: Adult; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Female; Hip | 2021 |
Effect and safety of topical application of tranexamic acid to reduce perioperative blood loss in elderly patients with intertrochanteric fracture undergoing PFNA.
Topics: Administration, Topical; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Blo | 2021 |
Tranexamic Acid in Pertrochanteric Femoral Fracture: Is it a Safe Drug or Not?
Topics: Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Transfusion; Female; Fracture Fixation, Intr | 2018 |
The Effect of Preoperative Administration of Intravenous Tranexamic Acid During Revision Hip Arthroplasty: A Retrospective Study.
Topics: Acetabulum; Aged; Aged, 80 and over; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood | 2018 |
Effects of topical tranexamic acid during open reduction and internal fixation of acetabular fractures: A retrospective study.
Topics: Acetabulum; Administration, Topical; Antifibrinolytic Agents; Blood Loss, Surgical; Blood Transfusio | 2019 |
Efficacy and safety of tranexamic acid in geriatric hip fracture with hemiarthroplasty: a retrospective cohort study.
Topics: Age Factors; Aged; Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Erythrocyte Tra | 2019 |
The efficacy of tranexamic acid in hip hemiarthroplasty surgery: an observational cohort study.
Topics: Aged, 80 and over; Antifibrinolytic Agents; Blood Loss, Surgical; Female; Hemiarthroplasty; Hip Frac | 2015 |
Tranexamic acid in hip fracture patients: a protocol for a randomised, placebo controlled trial on the efficacy of tranexamic acid in reducing blood loss in hip fracture patients.
Topics: Aged; Antifibrinolytic Agents; Arthroplasty, Replacement, Hip; Blood Loss, Surgical; Blood Transfusi | 2016 |